Articles dans des revues avec comité de lecture (368)
  1. 202. De Bruyn, C., Delforge, A., Bernier, M., & Bron, D. (2003). Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells. Cytotherapy, 5(1), 87-98. doi:10.1080/14653240310000119
  2. 203. De Bruyn, C., Delforge, A., & Bron, D. (2003). Ex vivo expansion of cord blood and mobilized peripheral blood CD34+ cells into megakaryocytes: detrimental effect of Flt3-ligand, stem cell factor and interleukin 3. Blood, 102, 421.
  3. 204. De Bruyn, C., Delforge, A., & Bron, D. (2003). Cord blood CD34+ cells do not differentiate successfully in megakaryocytes in vitro as compared with mobilized peripheral blood cells: negative effects of the addtion of stem cell factor to thrombopoietin. Experimental hematology, 31, 155.
  4. 205. Ruscas-Craciun, L. I., Stordeur, P., Schandené, L., Duvillier, H., Bron, D., Lambermont, M., Goldman, M., & Dupont, E. (2002). Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease. Transplantation, 74(7), 995-1000. doi:10.1097/01.TP.0000031933.82269.AC
  5. 206. Bron, D. (2002). Fatigue et qualité de vie chez les patients cancéreux. Revue médicale de Bruxelles, 23(4), A294-A298.
  6. 207. Snoeck, R., Andrei, G., Bodaghi, B., Lagneaux, L., Daelemans, D., de Clercq, E., Neyts, J., Schols, D., Naesens, L., Michelson, S., Bron, D., Otto, M. J., Bousseau, A., Nemecek, C., & Roy, C. (2002). 2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections. Antiviral research, 55(3), 413-424. doi:10.1016/S0166-3542(02)00074-8
  7. 208. Lewalle, P., Meuleman, N., Verhest, A., Bron, D., & Martiat, P. (2002). Infusion of peripheral blood stem cells collected at diagnosis, with maintenance of the treatment, resulted in Ph-negative recovery in a chronic myeloid leukaemia patient in persisting aplasia on STI-571 therapy. British journal of haematology, 118(1), 144-146. doi:10.1046/j.1365-2141.2002.03542.x
  8. 209. Bron, D., De Bruyn, C., Lagneaux, L., Tondreau, T., & Delforge, A. (2002). Les cellules souches hématopoiétiques: sources, indications et perspectives. Bulletin et mémoires de l'Académie royale de médecine de Belgique, 157(1-2), 135-45; discussion 145-6.
  9. 210. Bron, D., Labar, B., Suciu, S., Muus, P., Willemze, R., Marie, J. P., Fillet, G., Berneman, Z. N., Jaksic, B., Feremans, W., Sinnige, H., Mistrik, M., Vreudgenhil, G., De Bock, R., Nemet, D., Gilotay, C., Amadori, S., & De Witte, T. (2002). Stem cell transplantation in ALL: a donor versus no donor comparison in the EORTC ALL-4 study. Haematologica, 89(7), 809-817.
  10. 211. Lagneaux, L., Delforge, A., Dejeneffe, M., Massy, M., Bernier, M., & Bron, D. (2002). Hydroxychloriquine-induced apoptosis of chronic lymphocytic leukemia involves activation of caspase-3 and modulation of Bcl-2/bax/ratio. Leukemia & lymphoma, 43(5), 1087-1095.
  11. 212. Genot-Klastersky, M. T., Sekkaki, N., Crombez, P., Awada, A., Bron, D., & Klastersky, J. (2002). Low energy laser irradiation for the treatment of chemotherapy induced mucositis in bone marrow stem cell transplanted patients. Supportive care in cancer, 10, 32.
  12. 213. Bron, D. (2001). Bases physiopathologiques de l'anémie associée au cancer. Médecine et hygiène, 59(2352), 1409-1413.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 Suivant >>